Lurasidone Hydrochloride Tablet
Product Images NDC 68180-674

11 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 68180-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 01)

Image-01 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 01)
Chemical structure of lurasidone hydrochloride, showing its molecular framework including multiple rings, heteroatoms, and the hydrochloride component.*
FDA Label Image

Image-02 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 02)

Image-02 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 02)
A horizontal dot plot showing the fold change and 90% confidence intervals in pharmacokinetic parameters Cmax and AUC of lurasidone hydrochloride when co-administered with interacting drugs categorized as strong CYP3A4 inhibitor (ketoconazole 400 mg/day), moderate CYP3A4 inhibitor (diltiazem 240 mg/day), and strong CYP3A4 inducer (rifampin 600 mg/day) plus lithium 600 mg BID. The x-axis represents the change relative to lurasidone alone, ranging from -4 to 4.*
FDA Label Image

Image-03 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 03)

Image-03 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 03)
A horizontal forest plot chart showing fold changes and 90% confidence intervals for various pharmacokinetic parameters (Cmax, AUC, Ctrough) of interacting drugs compared to when taken alone. Drugs include P-gp substrates (Digoxin 0.25 mg SD), CYP3A4 substrates (Midazolam 5 mg SD), oral contraceptives (Ethinyl Estradiol, Norelgestromin), and Lithium 600 mg BID, with markers indicating relative change values along the x-axis.*
FDA Label Image

Image-04 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 04)

Image-04 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 04)
A pharmacokinetic chart showing fold change and 90% confidence intervals for Cmax and AUC under conditions of renal and hepatic impairment of varying severity, and by population characteristics including gender and race. The x-axis represents change relative to reference, illustrating the impact of these factors on drug concentration metrics.*
FDA Label Image

Image (98489a2d A33e 49d6 A23f 45932da3f7b0 793 1)

Image (98489a2d A33e 49d6 A23f 45932da3f7b0 793 1)
Chemical structure of lurasidone hydrochloride showing its molecular arrangement as depicted in the image.*
FDA Label Image

Image (1b0db25b 4dd9 49fc B2b0 B18157d73bca 815 1)

FDA Label Image

Image-06 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 05)

Image-06 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 05)
Label for Lurasidone Hydrochloride Tablets 20 mg oral tablets by Lupin Pharmaceuticals, Inc. The label states a package count of 30 tablets and includes dosage and storage instructions. The NDC is 68180-670-06. The label notes dispensing the medication guide to patients and includes a barcode and QR code for the medication guide.*
FDA Label Image

Image-07 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 06)

Image-07 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 06)
Label for Lurasidone Hydrochloride Tablets 40 mg by Lupin Pharmaceuticals, Inc., containing 30 tablets. The label includes the NDC 68180-671-06 and storage instructions at 25°C with allowed excursions. It advises pharmacists to dispense the medication guide to patients and features a QR code for access to the medication guide. Manufactured by Lupin Limited, India.*
FDA Label Image

Image-08 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 07)

Image-08 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 07)
Label for Lurasidone Hydrochloride Tablets 60 mg, oral tablets in a package of 30, labeled by Lupin Pharmaceuticals, Inc. The label includes the NDC 68180-672-06, storage instructions, and a QR code linking to the medication guide. Manufactured by Lupin Limited in India, with directions for pharmacists to dispense the medication guide to each patient.*
FDA Label Image

Image-09 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 08)

Image-09 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 08)
Label for Lurasidone Hydrochloride Tablets 80 mg by Lupin Pharmaceuticals, Inc., containing 30 tablets. The label includes the NDC 68180-673-06, manufacturer and storage information, a barcode, and a QR code for the medication guide. Tablets contain 80 mg lurasidone HCl, and the product is for prescription use only.*
FDA Label Image

Image-08 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 09)

Image-08 (8d77b0dd 8cc2 44da Afed 1e5cb75bed99 09)
Label for Lurasidone Hydrochloride Tablets 120 mg by Lupin Pharmaceuticals, Inc. The label shows that the package contains 30 oral tablets. It includes storage instructions and a barcode. The label also provides a website and QR code for the medication guide and notes that the product is manufactured in India by Lupin Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.